Wordt geladen...
Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases
BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) is a serine protease that inhibits the degradation of glucagon-like peptide 1. DPP-4 inhibitors are used worldwide to treat type 2 diabetes mellitus and were recently shown to have pleiotropic effects such as anti-oxidant, anti-inflammatory, and anti-fibrot...
Bewaard in:
| Gepubliceerd in: | BMC Nephrol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7501714/ https://ncbi.nlm.nih.gov/pubmed/32948146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-02060-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|